Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

BACKGROUND: One of the main difficulties of adoptive cell therapies with chimeric antigen receptor (CAR)-T cells in solid tumors is the identification of specific target antigens. The tumor microenvironment can present suitable antigens for CAR design, even though they are not expressed by the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Otal, Celia, Lasarte-Cia, Aritz, Serrano, Diego, Casares, Noelia, Conde, Enrique, Navarro, Flor, Sánchez-Moreno, Inés, Gorraiz, Marta, Sarrión, Patricia, Calvo, Alfonso, De Andrea, Carlos E, Echeveste, José, Vilas, Amaia, Rodriguez-Madoz, Juan Roberto, San Miguel, Jesús, Prosper, Felipe, Hervas-Stubbs, Sandra, Lasarte, Juan Jose, Lozano, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351345/
https://www.ncbi.nlm.nih.gov/pubmed/35918123
http://dx.doi.org/10.1136/jitc-2021-004479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351345/
https://www.ncbi.nlm.nih.gov/pubmed/35918123
http://dx.doi.org/10.1136/jitc-2021-004479

Ejemplares similares